Jan 23 (Reuters) - Ascentage Pharma Group International 6855.HK:
ASCENTAGE PHARMA ANNOUNCES PRICING OF U.S. INITIAL PUBLIC OFFERING
ASCENTAGE PHARMA GROUP INTERNATIONAL: PRICING OF ITS U.S. INITIAL PUBLIC OFFERING OF 7,325,000 ADS, AT A PUBLIC OFFERING PRICE OF $17.25 PER ADS
ASCENTAGE PHARMA GROUP INTERNATIONAL: TO BEGIN TRADING ON NASDAQ UNDER TICKER SYMBOL "AAPG" FOR "REGULAR-WAY" TRADING
Source text: ID:nGNXc0PCND
Further company coverage: 6855.HK
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.